New ZIRCON Phase III Data Presented at SNMMI: Potential Utility of TLX250-CDx in Staging and Monitoring ccRCC ...Middle East

MELBOURNE, Australia, June 26, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces further details of the positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell...

Hence then, the article about new zircon phase iii data presented at snmmi potential utility of tlx250 cdx in staging and monitoring ccrcc was published today ( Monday 26/06/2023 - 10:57 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New ZIRCON Phase III Data Presented at SNMMI: Potential Utility of TLX250-CDx in Staging and Monitoring ccRCC )

Also on site :

• UK to list 65-year-olds as reservists amid Russia threat claims – Telegraph
• Gaza plan phase two: US to discuss Hamas disarmament, Israeli withdrawal
• AI boom fuels fears of an industry bubble (VIDEO)